Related Experiment Video

Updated: May 31, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

[Diabetes and cardiovascular diseases in old age]

A Bahrmann1, P Bahrmann, A Zeyfang

  • 1AGAPLESION Bethanien-Krankenhaus, Geriatrisches Zentrum am Klinikum der Universität Heidelberg, Rohrbacher Strasse 149, Heidelberg, Germany. ankebahrmann@gmx.de

Zeitschrift Fur Gerontologie Und Geriatrie
|June 17, 2011
PubMed

Insights

Treating cardiovascular disease in elderly diabetics requires careful risk assessment. Tight blood sugar control (HbA1c <6%) can increase mortality; a target of 7-8% is generally recommended for geriatric patients with diabetes.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Endocrinology

Context:

  • Cardiovascular diseases (CVD) are a significant concern in elderly patients with diabetes mellitus.
  • Individualized treatment strategies are crucial for this population.
  • Balancing the risks and benefits of interventions is paramount.

Purpose:

  • To highlight the importance of individualized risk-benefit analysis in managing CVD in diabetic geriatric patients.
  • To caution against overly aggressive glycemic control in this demographic.
  • To provide a recommended target range for hemoglobin A1c (HbA1c) levels.

Summary:

  • Overtreatment of hyperglycemia, aiming for hemoglobin A1c (HbA1c) levels below 6%, is associated with increased mortality in geriatric patients with diabetes.
  • A more appropriate target HbA1c level for elderly individuals with diabetes mellitus is generally between 7% and 8%.
  • This approach emphasizes personalized care over strict metabolic targets to improve outcomes.

Impact:

  • Promotes safer treatment protocols for elderly diabetic patients with cardiovascular conditions.
  • Aims to reduce treatment-related mortality in this vulnerable population.
  • Encourages healthcare providers to adopt a nuanced approach to glycemic control in geriatric diabetes care.

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...